+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Injectable HIV Treatment Market - Global Forecast 2025-2030- Product Image
Injectable HIV Treatment Market - Global Forecast 2025-2030- Product Image
Sale

Injectable HIV Treatment Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6118567
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Injectable formulations for HIV therapy are redefining treatment standards by providing viable alternatives to daily oral regimens. Senior decision-makers in healthcare and life sciences are closely monitoring this dynamic landscape, as long-acting injectables promise improved adherence, reduced pill fatigue, and streamlined operational demands across patient populations.

Market Snapshot: Injectable HIV Therapy Market

The global injectable HIV therapy market is undergoing accelerated expansion, propelled by major regulatory approvals, the rollout of key agents, and the growing demand for patient-centric long-acting treatment solutions. Market adoption is influenced by a combination of clinical innovation, regulatory trends, and the integration of digital and decentralized care. Notably, recent advances in nanoemulsion and implant technologies are enabling extended dosing intervals and optimizing delivery for both patients and providers.

Scope & Segmentation of Injectable HIV Therapy

This report comprehensively addresses the breadth and depth of the injectable HIV therapy market. Segmentation is focused on diverse product classes, delivery intervals, care settings, and demographic considerations, underscoring the importance of tailored strategies for commercial success:

  • Product Types: Cabotegravir, Cabotegravir Plus Rilpivirine, Islatravir, Lenacapavir.
  • Dosing Frequencies: One month, two months, three months, six months.
  • Patient Experience: Treatment experienced, treatment naïve.
  • End Users: Clinics, home healthcare, hospitals.
  • Distribution Channels: Hospitals, retail pharmacies, specialty clinics.
  • Age Groups: Adolescents, adults, pediatrics.
  • Geographic Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (e.g., United Kingdom, Germany, France, UAE, South Africa, among others), Asia-Pacific (including China, India, Japan, Australia, and additional markets).
  • Industry Leaders Profiled: ViiV Healthcare Limited, Janssen Pharmaceuticals, Inc., Gilead Sciences, Inc., Merck & Co., Inc., Pfizer Inc., Shionogi & Co., Ltd., Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Viatris Inc.

Key Takeaways for Senior Decision-Makers

  • Long-acting injectable agents such as cabotegravir and its combinations are enabling new patient support and clinical management models beyond traditional oral therapies.
  • Decentralized administration—supported by telemedicine and digital adherence tools—extends care into home settings and creates logistical efficiencies for providers and payers.
  • Supply chain agility, especially for cold-chain dependent therapies, is vital to meet the operational requirements of multi-month dosing schedules and avoid distribution bottlenecks.
  • Segmentation by patient profile and care setting uncovers nuanced adoption drivers: adolescents, adults balancing comorbidities, and pediatrics each require tailored protocols and support mechanisms.
  • Collaborative partnerships between manufacturers and healthcare providers are fostering rapid scale-up, sustained adoption, and ongoing patient engagement programs.
  • Regional variations in reimbursement, infrastructure readiness, and epidemiological trends directly shape market-entry and expansion strategies.

United States Tariff Impacts on Injectable HIV Therapy

The implementation of U.S. tariffs in 2025 on key pharmaceutical components and specialized delivery materials has introduced a new set of operational complexities for manufacturers. These tariffs are increasing production costs, prompting companies to adjust sourcing strategies, negotiate phased exemptions for essential inputs, and intensify engagement with payers to safeguard patient access. Stakeholders must closely monitor evolving policy and invest in risk mitigation to maintain supply reliability and cost-effectiveness.

Methodology & Data Sources

Insights within this report are drawn from robust qualitative and quantitative methodologies. Secondary research involved analysis of peer-reviewed journals, regulatory filings, and market trend studies. Primary data was obtained through interviews with leading clinicians, payers, and patient advocacy groups, ensuring practical perspectives on adoption patterns and operational challenges. Segmentation and regional overlays were validated through structured survey feedback and expert review.

Primary Keyword: Injectable HIV Therapy

Why This Report Matters

  • Supports informed decision-making with actionable segmentation insights, regional comparisons, and profiles of key market participants.
  • Equips market entrants and incumbents with scenario planning tools to navigate the evolving regulatory, supply chain, and reimbursement landscape.
  • Enables commercial, clinical, and supply-chain leaders to benchmark their strategies in alignment with emerging patient and provider expectations.

Conclusion

Injectable HIV therapy is shaping the next evolution of HIV treatment, with innovative delivery models, adaptive supply chains, and strategic engagement driving sustainable market growth. This report delivers the essential market intelligence for shaping successful, patient-focused strategies amid ongoing industry change.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Assessing real-world adherence patterns and outcomes for long-acting injectable HIV regimens
5.2. Evaluating the impact of novel biodegradable injectable formulations on patient retention in HIV care
5.3. Analyzing payer coverage trends and reimbursement challenges for second-generation HIV injectables in the US market
5.4. Assessing supply chain resilience amid manufacturing scale-up of long-acting injectable HIV antiretrovirals globally
5.5. Investigating patient preference shifts towards monthly versus bimonthly HIV injectable therapy dosing schedules
5.6. Scaling digital health platforms to support remote monitoring of patients on injectable HIV treatments
5.7. Monitoring emerging competition from generic long-acting injectable HIV drugs in key global markets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Injectable HIV Treatment Market, by Product Type
8.1. Introduction
8.2. Cabotegravir
8.3. Cabotegravir Plus Rilpivirine
8.4. Islatravir
8.5. Lenacapavir
9. Injectable HIV Treatment Market, by Dosing Frequency
9.1. Introduction
9.2. One Month
9.3. Three Months Or More
9.3.1. Six Months
9.3.2. Three Months
9.4. Two Months
10. Injectable HIV Treatment Market, by Patient Experience
10.1. Introduction
10.2. Treatment Experienced
10.3. Treatment Naïve
11. Injectable HIV Treatment Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Healthcare
11.4. Hospitals
12. Injectable HIV Treatment Market, by Distribution Channel
12.1. Introduction
12.2. Hospitals
12.3. Retail Pharmacies
12.4. Specialty Clinics
13. Injectable HIV Treatment Market, by Age Group
13.1. Introduction
13.2. Adolescents
13.3. Adults
13.4. Pediatrics
14. Americas Injectable HIV Treatment Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Injectable HIV Treatment Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Injectable HIV Treatment Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. ViiV Healthcare Limited
17.3.2. Janssen Pharmaceuticals, Inc.
17.3.3. Gilead Sciences, Inc.
17.3.4. Merck & Co., Inc.
17.3.5. Pfizer Inc.
17.3.6. Shionogi & Co., Ltd.
17.3.7. Bristol-Myers Squibb Company
17.3.8. Teva Pharmaceutical Industries Ltd.
17.3.9. Sandoz International GmbH
17.3.10. Viatris Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. INJECTABLE HIV TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS INJECTABLE HIV TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS INJECTABLE HIV TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES INJECTABLE HIV TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES INJECTABLE HIV TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC INJECTABLE HIV TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC INJECTABLE HIV TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. INJECTABLE HIV TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. INJECTABLE HIV TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. INJECTABLE HIV TREATMENT MARKET: RESEARCHAI
FIGURE 28. INJECTABLE HIV TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 29. INJECTABLE HIV TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 30. INJECTABLE HIV TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. INJECTABLE HIV TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY CABOTEGRAVIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY CABOTEGRAVIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY CABOTEGRAVIR PLUS RILPIVIRINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY CABOTEGRAVIR PLUS RILPIVIRINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY ISLATRAVIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY ISLATRAVIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY LENACAPAVIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY LENACAPAVIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY ONE MONTH, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY ONE MONTH, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY SIX MONTHS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY SIX MONTHS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY TWO MONTHS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY TWO MONTHS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY TREATMENT EXPERIENCED, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY TREATMENT EXPERIENCED, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY TREATMENT NAÏVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY TREATMENT NAÏVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY ADOLESCENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL INJECTABLE HIV TREATMENT MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS INJECTABLE HIV TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS INJECTABLE HIV TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES INJECTABLE HIV TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES INJECTABLE HIV TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 95. CANADA INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 96. CANADA INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 97. CANADA INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 98. CANADA INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 99. CANADA INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2018-2024 (USD MILLION)
TABLE 100. CANADA INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2025-2030 (USD MILLION)
TABLE 101. CANADA INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2018-2024 (USD MILLION)
TABLE 102. CANADA INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2025-2030 (USD MILLION)
TABLE 103. CANADA INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. CANADA INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. CANADA INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. CANADA INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. CANADA INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 108. CANADA INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 109. MEXICO INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 110. MEXICO INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 111. MEXICO INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 112. MEXICO INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 113. MEXICO INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2018-2024 (USD MILLION)
TABLE 114. MEXICO INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2025-2030 (USD MILLION)
TABLE 115. MEXICO INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2018-2024 (USD MILLION)
TABLE 116. MEXICO INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2025-2030 (USD MILLION)
TABLE 117. MEXICO INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. MEXICO INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. MEXICO INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. MEXICO INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. MEXICO INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 122. MEXICO INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 181. GERMANY INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. GERMANY INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. GERMANY INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 184. GERMANY INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 185. GERMANY INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2018-2024 (USD MILLION)
TABLE 186. GERMANY INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2025-2030 (USD MILLION)
TABLE 187. GERMANY INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2018-2024 (USD MILLION)
TABLE 188. GERMANY INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2025-2030 (USD MILLION)
TABLE 189. GERMANY INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. GERMANY INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. GERMANY INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. GERMANY INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. GERMANY INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 194. GERMANY INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 195. FRANCE INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 196. FRANCE INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 197. FRANCE INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 198. FRANCE INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 199. FRANCE INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2018-2024 (USD MILLION)
TABLE 200. FRANCE INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2025-2030 (USD MILLION)
TABLE 201. FRANCE INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2018-2024 (USD MILLION)
TABLE 202. FRANCE INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2025-2030 (USD MILLION)
TABLE 203. FRANCE INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. FRANCE INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. FRANCE INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. FRANCE INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. FRANCE INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 208. FRANCE INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 223. ITALY INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. ITALY INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. ITALY INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 226. ITALY INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 227. ITALY INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2018-2024 (USD MILLION)
TABLE 228. ITALY INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2025-2030 (USD MILLION)
TABLE 229. ITALY INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2018-2024 (USD MILLION)
TABLE 230. ITALY INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2025-2030 (USD MILLION)
TABLE 231. ITALY INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. ITALY INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. ITALY INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. ITALY INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. ITALY INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 236. ITALY INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 237. SPAIN INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. SPAIN INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. SPAIN INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 240. SPAIN INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 241. SPAIN INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2018-2024 (USD MILLION)
TABLE 242. SPAIN INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2025-2030 (USD MILLION)
TABLE 243. SPAIN INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2018-2024 (USD MILLION)
TABLE 244. SPAIN INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2025-2030 (USD MILLION)
TABLE 245. SPAIN INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. SPAIN INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. SPAIN INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. SPAIN INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. SPAIN INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 250. SPAIN INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 293. DENMARK INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 294. DENMARK INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 295. DENMARK INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 296. DENMARK INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 297. DENMARK INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2018-2024 (USD MILLION)
TABLE 298. DENMARK INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2025-2030 (USD MILLION)
TABLE 299. DENMARK INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2018-2024 (USD MILLION)
TABLE 300. DENMARK INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2025-2030 (USD MILLION)
TABLE 301. DENMARK INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. DENMARK INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. DENMARK INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. DENMARK INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. DENMARK INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 306. DENMARK INJECTABLE HIV TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS INJECTABLE HIV TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS INJECTABLE HIV TREATMENT MARKET SIZE, BY DOSING FREQUENCY, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS INJECTABLE HIV TREATMENT MARKET SIZE, BY THREE MONTHS OR MORE, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS INJECTABLE HIV TREATMENT MARKET SIZE, BY PATIENT EXPERIENCE, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS INJECTABLE HIV TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. NETHERLANDS INJECTABLE HIV TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. NETH

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Injectable HIV Treatment market report include:
  • ViiV Healthcare Limited
  • Janssen Pharmaceuticals, Inc.
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Shionogi & Co., Ltd.
  • Bristol-Myers Squibb Company
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Viatris Inc.

Related Topics

Related Reports

Injectable HIV Medication Market - Global Forecast 2025-2030 - Product Image

Injectable HIV Medication Market - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
HIV Injections - Global Strategic Business Report - Product Image

HIV Injections - Global Strategic Business Report

  • Report
  • 182 Pages
  • Global
From
HIV-Associated Lipodystrophy - Global Strategic Business Report - Product Image

HIV-Associated Lipodystrophy - Global Strategic Business Report

  • Report
  • 271 Pages
  • Global
From
Human Immunodeficiency Virus (HIV1) Infection Market Outlook - Forecast Trends, Market Size, Share and Growth Analysis Report (2025-2034) - Product Image

Human Immunodeficiency Virus (HIV1) Infection Market Outlook - Forecast Trends, Market Size, Share and Growth Analysis Report (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Human Immunodeficiency Virus Hiv 1 Infection Market - Product Image

Human Immunodeficiency Virus Hiv 1 Infection Market

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.